Keros Therapeutics, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -123.36%758,883.33%-315.18%10,467,900.00%-101,319.21%-5,269.10%
EBIT Margin -105.63%777,616.67%-313.18%11,479,000.00%-112,543.71%-5,938.96%
EBITDA Margin -105.63%777,616.67%-313.18%11,479,000.00%-112,543.71%-5,938.96%
Operating Margin -105.63%777,616.67%-313.18%11,479,000.00%-112,543.71%-5,938.96%
Net Margin -141.36%756,016.67%-326.36%10,467,900.00%-101,319.21%-5,277.55%
FCF Margin -162.69%619,800.00%-350.96%7,130,300.00%-84,087.42%-4,585.92%
Efficiency
Assets Average 140.20M262.35M281.02M338.40M492.96M
Equity Average 121.14M252.45M260.30M304.82M451.88M
Invested Capital -19.45M261.72M243.17M277.42M332.21M571.55M
Asset Utilization Ratio 0.000.070.000.000.01
Leverage & Solvency
Interest Coverage Ratio -0.01M-0.01M-0.11M
Equity Ratio -1.780.970.950.900.900.93
Times Interest Earned -0.01M-0.01M-0.11M
Valuation
Enterprise Value -7.02M1,158.21M1,139.01M1,043.58M860.04M81.30M
Market Capitalization 1,424.09M1,369.06M1,322.63M1,191.18M641.23M
Return Ratios
Return on Sales -1.23%-3.26%-52.78%
Return on Capital Employed -0.35%-0.23%-0.43%-0.54%-0.45%
Return on Invested Capital -0.38%
Return on Assets -0.32%-0.22%-0.37%-0.45%-0.38%
Return on Equity -0.37%-0.23%-0.40%-0.50%-0.41%